Published in Eur J Clin Microbiol Infect Dis on December 14, 2011
Is fidaxomicin worth the cost? An economic analysis. Clin Infect Dis (2013) 2.22
Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality. Eur J Clin Microbiol Infect Dis (2014) 0.92
A clinical and epidemiological review of non-toxigenic Clostridium difficile. Anaerobe (2013) 0.91
Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool. J Clin Microbiol (2014) 0.89
Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection. Eur J Clin Microbiol Infect Dis (2013) 0.87
Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China. BMC Infect Dis (2014) 0.84
Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy. Springerplus (2016) 0.79
Reducing inappropriate antibiotic prescribing in the residential care setting: current perspectives. Clin Interv Aging (2014) 0.78
Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile. Open Forum Infect Dis (2014) 0.78
Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample. BMC Infect Dis (2015) 0.78
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. BMC Infect Dis (2016) 0.75
Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk. Microbiome (2016) 0.75
An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med (2005) 18.10
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59
Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol (1997) 8.81
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis (2001) 6.92
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ (2005) 5.59
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ (2004) 4.88
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis (2007) 4.77
The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev (2010) 4.48
Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology (2009) 3.29
A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. Clin Infect Dis (2006) 2.85
Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol (2003) 2.24
A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis (2004) 1.96
Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol (2009) 1.85
Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.78
Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther (2006) 1.61
Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.57
Pseudomembranous colitis: causes and cures. Digestion (1999) 1.35
The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol (2009) 1.16
Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan. Antimicrob Agents Chemother (2011) 1.10
Asymptomatic Clostridium difficile colonization: is this the tip of another iceberg? Clin Infect Dis (2007) 1.06
Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med (1996) 1.06
Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis (2011) 1.00
Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect (2010) 0.97
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease. Eur J Clin Microbiol Infect Dis (2010) 0.96
The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalized patients. Postgrad Med J (1993) 0.94
Clostridium difficile-associated colitis. Can Fam Physician (2004) 0.88
Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem. Clin Gastroenterol Hepatol (2007) 0.84
Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea. Anaerobe (2009) 0.81
C. difficile infection (CDI) in a long-term acute care facility (LTAC). Anaerobe (2009) 0.75
The Ensembl genome database project. Nucleic Acids Res (2002) 40.87
Ensembl 2009. Nucleic Acids Res (2008) 25.38
Ensembl 2008. Nucleic Acids Res (2007) 20.67
Ensembl 2007. Nucleic Acids Res (2006) 20.10
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Ensembl 2005. Nucleic Acids Res (2005) 15.13
Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res (2003) 12.26
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol (1992) 12.13
Ensembl 2004. Nucleic Acids Res (2004) 11.88
Ensembl 2006. Nucleic Acids Res (2006) 11.66
Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1976) 9.38
Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria. Antimicrob Agents Chemother (1973) 9.35
Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol (1977) 8.29
Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob Agents Chemother (1987) 7.33
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol (2001) 6.68
Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol (2000) 6.46
Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol (1991) 6.17
RANK is essential for osteoclast and lymph node development. Genes Dev (1999) 5.85
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis (1994) 5.44
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Redesigning health care. BMJ (2001) 5.43
Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1979) 5.10
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood (2000) 5.06
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
Biological activities of toxins A and B of Clostridium difficile. Infect Immun (1982) 4.62
Development of a micromethod for identification of anaerobic bacteria. Appl Microbiol (1975) 4.58
Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi. J Clin Microbiol (1991) 4.56
Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature (1984) 4.28
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol (1994) 4.27
TB policy and the badger culling trials. Vet Rec (2006) 4.14
Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med (2000) 4.14
Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol (1977) 4.09
Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06
Production of Clostridium difficile antitoxin. Infect Immun (1980) 3.95
The clinical and laboratory diagnosis of Trichomonas vaginalis infection. Sex Transm Dis (1981) 3.89
TB policy and the badger culling trials. Vet Rec (2006) 3.84
Micromethod for identification of anaerobic bacteria: design and operation of apparatus. Appl Microbiol (1975) 3.80
The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry (1990) 3.75
Systematic review of multidisciplinary interventions in heart failure. Heart (2005) 3.68
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67
Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol (2001) 3.53
The "redisorganisation" of the NHS. BMJ (2001) 3.52
Effect of low-level body burdens of lead on the mental development of children: limitations of meta-analysis in a review of longitudinal data. Arch Environ Health (1992) 3.42
Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40
Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem (1999) 3.35
Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect (2004) 3.27
Cervical screening in Perth and Kinross since introduction of the new contract. BMJ (1991) 3.20
A low resolution structure for the histone core of the nucleosome. Nature (1980) 3.17
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg (1995) 3.08
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer (1998) 3.03
Public health gets a boost in NHS streamlining. BMJ (1994) 3.03
Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol Microbiol (1999) 2.99
WEIL'S DISEASE (LEPTOSPIROSIS): A CLINICAL AND BACTERIOLOGICAL STUDY OF NINETEEN CASES OCCURRING CHIEFLY AMONG FISH WORKERS. Br Med J (1934) 2.99
The dynamics of chromosome evolution in birds and mammals. Nature (1999) 2.95
Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res (1990) 2.93
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr (1983) 2.89
Women prefer hospital births. BMJ (1992) 2.88
Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J Clin Microbiol (1982) 2.86
Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology (1998) 2.81
Competing demands from physical problems: effect on initiating and completing depression care over 6 months. Arch Fam Med (2001) 2.77
MvirDB--a microbial database of protein toxins, virulence factors and antibiotic resistance genes for bio-defence applications. Nucleic Acids Res (2006) 2.76
The role of competing demands in the treatment provided primary care patients with major depression. Arch Fam Med (2000) 2.75
Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70
Arginine, a growth-limiting factor for Eubacterium lentum. J Bacteriol (1976) 2.67
Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis (1997) 2.65
Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65
Results of provider self-adjudication using the prudent layperson standard compared with the managed care organization's emergency department claim review process. Ann Emerg Med (2000) 2.64
Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocket. J Biol Chem (1998) 2.62
Production by Salmonella typhimurium of 2,3-dihydroxybenzoylserine, and its stimulation of growth in human serum. J Infect Dis (1970) 2.62
The purified yeast pre-mRNA splicing factor PRP2 is an RNA-dependent NTPase. EMBO J (1992) 2.60
Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol (1996) 2.60
London's health care again. BMJ (1992) 2.56
Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention. Quality Enhancement by Strategic Teaming. J Gen Intern Med (2001) 2.56
Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400. J Infect Dis (1978) 2.51
Improving London's health service. BMJ (1993) 2.50
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.49
Medium-dependent inhibition of Peptostreptococcus anaerobius by sodium polyanetholsulfonate in blood culture media. J Clin Microbiol (1976) 2.46
Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol (1985) 2.46
Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr (1982) 2.41
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ (1997) 2.41
Comparison of 16S rRNA sequences of segmented filamentous bacteria isolated from mice, rats, and chickens and proposal of "Candidatus Arthromitus". Int J Syst Bacteriol (1995) 2.39
Medical students' clinical self-assessments: comparisons with external measures of performance and the students' self-assessments of overall performance and effort. Acad Med (1993) 2.30
Gift authorship: a poisoned chalice? BMJ (1994) 2.30
Dominance in lambda S mutations and evidence for translational control. J Mol Biol (1988) 2.24
NHS reorganisation. Cause and effect. Health Serv J (2001) 2.23
American Orthopaedic Foot and Ankle Society women's shoe survey. Foot Ankle (1993) 2.23
Is age-related stability of subjective well-being a paradox? Cross-sectional and longitudinal evidence from the Berlin Aging Study. Psychol Aging (2000) 2.20
Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med (1987) 2.20
Dissociation of Pavlovian and instrumental incentive learning under dopamine antagonists. Behav Neurosci (2000) 2.18
Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J Infect Dis (1991) 2.17